Product Information
CIMETIDINE 300 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2332 per EA under NDC 00093819201. Its NADAC has been published 631 times since Nov 28, 2013.
The Low Outlier badge above means this manufacturer's average price in the Cimetidine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093819201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIMETIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA074151On Market Since
11/24/2003
Pharmacological Classes
Price Statistics
The NADAC for CIMETIDINE 300 MG TABLET has been published 631 times since Nov 28, 2013, and over the history we have for it it has risen 43.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2332 per EA |
|---|---|
| All-time high | $0.3868 (Sep 14, 2016) |
| All-time low | $0.1500 (Sep 17, 2014) |
| 52-week high | $0.2897 |
| 52-week low | $0.2332 |
| Median price | $0.2941 |
| Average price | $0.2853 |
| Largest weekly change | +47.8% (Oct 21, 2015) |
| Weeks tracked | 631 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CIMETIDINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CIMETIDINE 300 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2332 per EA (NDC 00093819201), effective Jun 24, 2026.
How has the price of CIMETIDINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for CIMETIDINE 300 MG TABLET has risen 43.5%. It has been tracked across 631 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIMETIDINE 300 MG TABLET?
Since Nov 28, 2013, the NADAC for CIMETIDINE 300 MG TABLET has ranged from a low of $0.1500 (Sep 17, 2014) to a high of $0.3868 (Sep 14, 2016), with a median of $0.2941 per EA.
Are there cheaper alternatives to CIMETIDINE 300 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CIMETIDINE 300 MG TABLET, but none are currently priced below it.
Who manufactures CIMETIDINE 300 MG TABLET?
CIMETIDINE 300 MG TABLET (NDC 00093819201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification